374Water (SCWO) 10-K 17 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 17, 2014	Jun. 28, 2013
Document and Entity Information:	'	'	'
Entity Registrant Name	'POWERVERDE, INC.	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Entity Central Index Key	'0000933972	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Common Stock, Shares Outstanding	'	30,000,106	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Public Float	'	'	$4,100,000

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets:	'	'
Cash and cash equivalents	$48,306	$45,283
Accounts receivable	49,844	115,687
Employee advances,	19,292	'
Prepaid expenses	18,366	46,641
Total Current Assets	135,808	207,611
Property and Equipment	'	'
Property and equipment, net of accumulated depreciation of $38,616 and $26,771, respectively	55,434	9,559
Other Assets	'	'
Intellectual property, net of accumulated amortization of $384,673 and $164,860, respectively	274,767	494,580
Total Assets	466,009	711,750
Current Liabilities	'	'
Accounts payable and accrued expenses	43,575	109,568
Payable to related parties	163,965	170,764
Notes payable to related parties	314,140	184,367
Total Current Liabilities	521,680	280,332
Long-Term Liabilities	'	'
Derivative liability	'	68,250
Notes payable to related parties,	'	184,367
Total Long-Term Liabilities	'	252,617
Total Liabilities	521,680	532,949
Common stock:	'	'
100,000,000 common shares authorized, par value $0.0001 per share, 27,600,106 common shares issued and outstanding at December 31, 2013 and 26,011,565 common shares issued and outstanding at December 31, 2012	3,567	3,414
Additional paid-in capital	11,098,665	10,278,331
Treasury stock, 8,550,000 shares at cost	-491,139	-491,139
Deficit accumulated in the development stage	-10,666,764	-9,611,805
Total Stockholders' Equity (Deficiency)	-55,671	178,801
Total Liabilities and Stockholders' Equity (Deficiency)	$466,009	$711,750

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets Parentheticals (USD $)	Dec. 31, 2013	Dec. 31, 2012
Parentheticals	'	'
Property and equipment, net of accumulated depreciation	$38,616	$26,771
Intellectual Property, net of accumulated amortization	$384,673	$164,860
Common Stock, no par value	$0.00	$0.00
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	27,600,106	26,011,565
Common Stock, shares outstanding	27,600,106	26,011,565
Treasury stock	8,550,000	8,550,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	12 Months Ended		82 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Revenues:	'	'	'
Revenue, Net	$359,362	$193,692	$837,811
Cost of Goods Sold	'	'	136,925
Gross Profit	359,362	193,692	700,886
Operating Expenses	'	'	'
Research and development	459,651	1,321,214	3,788,545
General and administrative	844,259	978,818	4,494,689
Goodwill impairment	'	2,637,760	2,637,760
Total Operating Expenses	1,303,910	4,937,792	10,920,994
Loss from Operations	-944,548	-4,744,100	-10,220,108
Other Income (Expenses)	'	'	'
Interest income	'	'	2,401
Interest expense	-147,161	-14,200	-505,068
Other income (expenses)	36,750	3,250	56,011
Total Other Income (Expenses)	-110,411	-10,950	-446,656
Loss before Income Taxes	-1,054,959	-4,755,050	-10,666,764
Net Loss	($1,054,959)	($4,755,050)	($10,666,764)
Net Loss per Share - Basic and Diluted	($0.04)	($0.18)	'
Weighted Average Common Shares Outstanding - Basic and Diluted	26,865,503	27,134,392	'

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Stockholders' Equity (USD $)	Common Stock Shares	Common Stock Amount	Additional Paid in Capital	Treasury Stock Amount	Deficit Accumulated during the Development Stage	Total Stockholders' Equity
	USD ($)	USD ($)	USD ($)		USD ($)	USD ($)
Balances , at Mar. 09, 2007	0	'	'	'	'	'
Common Stock issued for cash, net of stock issuance costs of $45,398	20,350,000	20,350	659,252	'	'	679,602
Net Loss	'	'	'	'	($274,402)	($274,402)
Balances , at Dec. 31, 2007	20,350,000	20,350	659,252	'	-274,402	405,200
Sale of common stock at $.50 per share	50,000	50	24,950	'	'	25,000
Stockholder Equity of Vyrex Corporation at merger	1,019,144	102	-479,771	'	'	-479,669
Recapitalization of PowerVerde stockholders' equity	-20,400,000	-20,400	20,400	'	'	'
Shares issued related to forgiveness of debt and issued for services	275,000	28	249,972	'	'	250,000
Shares issued in exchange for PowerVerde shares	24,588,734	2,459	-2,459	'	'	'
Warrants issued with debt	'	'	299,984	'	'	299,984
Net loss	'	'	'	'	-829,556	-829,556
Balances , at Dec. 31, 2008	25,882,878	2,589	772,328	'	-1,103,958	-329,041
Sale of common stock at $.75 per share, net of stock issuance costs of $85,000	1,266,667	126	864,874	'	'	865,000
Common stock issued on conversion of debt	378,521	38	189,223	'	'	189,261
Common stock issued for services	75,000	8	56,242	'	'	56,242
Net loss	'	'	'	'	-890,980	-890,980
Balances , at Dec. 31, 2009	27,603,066	2,761	1,882,667	'	-1,994,938	-109,510
Sale of common stock at $.75 per share, net of stock issuance costs of $85,000	439,999	43	296,958	'	'	297,001
Net loss	'	'	'	'	-308,352	-308,352
Balances , at Dec. 31, 2010	28,043,065	2,804	2,179,625	'	-2,303,290	-120,861
Sale of common stock at $.75 per share, net of stock issuance costs of $150,000	2,000,000	200	1,349,800	'	'	1,350,000
Stock-based compensation	'	'	466,907	'	'	466,907
Warrants issued for services	'	'	612,150	'	'	612,150
Warrants exercised	81,500	8	122,242	'	'	122,250
Treasury stock	-4,500,000	'	'	-170,758	'	-170,758
Net loss	'	'	'	'	-2,553,465	-2,553,465
Balances , at Dec. 31, 2011	25,624,565	3,012	4,730,724	-170,758	-4,856,755	-293,777
Sale of 906,000 shares of common stock at $1.00 per share, 450,000 at $.715 per share and 396,000 shares at $.43 per share, net of stock issuance costs of $139,803	1,752,000	176	1,258,052	'	'	1,258,228
Issuance of warrants for settlement with Newton	'	'	262,700	'	'	262,700
Stock-based compensation	'	'	658,381	'	'	658,381
Issuance of common stock at $1.37 per share for Cornerstone acquisition	2,260,000	226	3,095,974	'	'	3,096,200
Issuance of warrants for Cornerstone acquisition	'	'	201,000	'	'	201,000
Cancellation of shares issued for services to Del Mar Consulting	-75,000	'	'	'	'	'
Warrants issued in connection with notes payable to related party	'	'	71,500	'	'	71,500
Treasury stock	-3,550,000	'	'	-320,381	'	-320,381
Net loss	'	'	'	'	-4,755,050	-4,755,050
Balances , at Dec. 31, 2012	26,011,565	3,414	10,278,331	-491,139	-9,611,805	178,801
Warrants issued for services	'	'	210,000	'	'	210,000
Sale of common stock at $.25 per share	1,200,000	121	299,879	'	'	300,000
Common stock issued for services	325,000	32	124,718	'	'	124,750
Stock-based compensation	'	'	121,237	'	'	121,237
Warrants issued in connection with Notes payable to related party	'	'	16,500	'	'	16,500
Warrants issued in connection with derivative liability	'	'	48,000	'	'	48,000
Common stock issued on conversion of debt	44,791	'	'	'	'	'
Cashless exercise of options	18,750	'	'	'	'	'
Net loss	'	'	'	'	($1,054,959)	($1,054,959)
Balances , at Dec. 31, 2013	27,600,106	3,567	11,098,665	-491,139	-10,666,764	-55,671

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (USD $)	12 Months Ended		82 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Cash Flows from Operating Activities	'	'	'
Net loss.	($1,054,959)	($4,755,050)	($10,666,764)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation and amortization	231,658	171,110	423,289
Amortization of discount	87,773	13,521	440,986
Stock based compensation	121,237	658,381	1,302,767
Common stock issued for services	124,750	'	124,750
Goodwill impairment	'	2,637,760	2,637,760
Warrants issued for services	210,000	'	822,150
Warrants issued for settlement	0	262,700	262,700
Gain on re-measurement of derivative liability	-36,750	-3,250	-40,000
Changes in operating assets and liabilities	'	'	'
Accounts receivable and prepaid expenses	94,118	-119,152	-68,210
Employee advances	-19,292	'	-19,292
Accounts payable and accrued expenses	-65,993	-69,736	-186,957
Payable to related parties	-6,799	159,611	152,812
Cash Used in Operating Activities	-314,257	-1,044,105	-4,814,009
Cash Flows From Investing Activities	'	'	'
Purchase of property and equipment	-57,720	'	-94,050
Cash acquired in business acquisition	'	'	872
Cash Used in Investing Activities	-57,720	'	-93,178
Cash Flows from Financing Activities	'	'	'
Proceeds from issuance of common stock	300,000	1,398,031	5,350,281
Proceeds from notes payable to related parties	75,000	325,000	700,000
Payment of line of credit	'	'	-50,000
Payment of note payable to related parties	'	-180,989	-271,206
Purchase of treasury stock	'	-320,381	-320,381
Payment of stock issuance costs	'	-139,803	-453,201
Cash Provided by Financing Activities	375,000	1,081,858	4,995,493
Net Increase in Cash and Cash Equivalents	3,023	37,753	48,306
Cash and cash equivalents at Beginning of Period	45,283	7,530	'
Cash and cash equivalents at End of Period	48,306	45,283	48,306
Supplemental Disclosure of Cashflow Information	'	'	'
Cash Paid for Interest	20,705	'	20,705
Cash Paid for Income Taxes	'	'	24,221
Supplemental Schedule of Non-Cash Financing	'	'	'
Common stock issued for convertible debt	'	'	189,261
Common stock issued for services	124,750	'	124,750
Common stock issued for acquisition of Cornerstone Conservation Group, LLC	'	3,096,200	3,096,200
Warrants issued in connection with acquisition of Cornerstone Conservation Group, LLC	'	201,000	201,000
Purchase of treasury stock with long-term related party payable	'	72,000	242,758
Warrants issued in connection with debt	'	'	299,984
Issuance of warrants as part of notes payable to related party of which $88,000 ($16,5000 in Q1 2013) was classified as additional paid in capital and $88,000 ($16,500 in Q1 2013) was classified as a derivative liability	176,000	'	176,000
Warrants issued in connection with derivative liability	48,000	'	48,000
Common stock issued in connection with debt forgiveness and services rendered	'	'	$250,000

Nature_of_Business

Nature of Business	12 Months Ended
	Dec. 31, 2013
Nature of Business	'
Nature of Business	'
	Note 1 – Nature of Business
	PowerVerde, Inc. (the “Company”) is a “C” Corporation organized under the Laws of Delaware with operations in Scottsdale, Arizona. The Company’s two founders, now its largest shareholders, have conceived and developed the use of a power systems patent. The Company is in the development stage and it is presently undertaking research and development on a power generating system.
	On February 11, 2008, Vyrex Corporation (“Vyrex” or the “Company”); PowerVerde, Inc. (“PowerVerde”) and Vyrex Acquisition Corporation (“VAC”), a wholly-owned subsidiary of Vyrex, all Delaware corporations, entered into an Agreement and Plan of Merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on February 12, 2008, VAC merged with and into PowerVerde, with PowerVerde remaining as the surviving corporation and a wholly-owned subsidiary of Vyrex (the “Merger”). As consideration for the Merger, as of the closing of the Merger, each issued and outstanding share of common stock of PowerVerde was converted into the right to receive 1.2053301 shares of the common stock of Vyrex and each share of VAC was converted into one share of PowerVerde common stock. As a result of the Merger, the former shareholders of PowerVerde held 24,588,734 shares, or 95%, of the common stock of Vyrex. Pursuant to the Merger Agreement, PowerVerde paid $233,000 in accounts payable and other liabilities owed by Vyrex. The total purchase price of the transaction of $401,894 includes $60,000 of transaction costs related to the Merger.
	In addition, immediately prior to execution of the Merger Agreement, Vyrex paid a $200,000 promissory note through the issuance of 250,000 shares of common stock and issued an additional 25,000 shares of common stock as payment for certain consulting and administrative services.
	At a stockholder meeting held on August 6, 2008, the Company’s stockholders approved (i) the change of the Company’s name to “PowerVerde, Inc.” and (ii) the Amended and Restated Certificate of Incorporation filed as an exhibit to the Company’s report on Form 10-Q for the quarter ended June 30, 2008. Immediately prior to the filing of the Certificate changing the Company’s name, the name of the Company’s operating subsidiary was changed from “PowerVerde, Inc.” To “PowerVerde Systems, Inc.”

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2013
Going Concern:	'
Going Concern	'
	Note 2 – Going Concern
	The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has had recurring operating losses and negative cashflows from operations. Those factors, as well as uncertainty in securing additional funds for continued operations, create an uncertainty about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies	'
Summary of Significant Accounting Policies	'
	Note 3 – Summary of Significant Accounting Policies
	Principles of Consolidation
	The consolidated financial statements include the accounts of PowerVerde, Inc. and its wholly-owned subsidiary, PowerVerde Systems, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.
	Development Stage Company
	The Company is a development stage company as defined in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 915, “Development Stage Entities”. The Company is devoting substantially all of its present efforts to establish a new business and none of its planned principal operations have commenced. All losses accumulated since inception has been considered as part of the Company’s development stage activities.
	Cash Equivalents
	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
	Accounts Receivable
	Accounts receivable consist of balances due from sales and royalties. The Company monitors accounts receivable and provides allowances when considered necessary. At December 31, 2013 and 2012, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.
	Employee Advances
	The employee advances represent the payroll taxes due on the issuance of common stock as compensation.
	Revenue Recognition
	Sales revenues and associated cost of sales are recognized when title of the goods sold pass to the buyer, when shipped and when accounts receivable are determined to be reasonable collectable. Certain sales agreements also require installation and training by PowerVerde once goods are received and accepted by the customer. The Company does not consider these agreements multiple elements arrangements as defined by ASC 605-25 “Revenue Recognition”, as the Company does not offer installation or training as services separate from the sale of its products at this time. Therefore, a “best estimate of selling price” or individual pricing in accordance with ASC 605-25 is undeterminable. The Company defers all revenues and costs of sales until the agreement is 100% complete.
	Licensing and royalty revenue from royalty agreements is recognized in accordance with the terms of the specific agreement.
	Property and Equipment
	Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.
	Intellectual Property and Goodwill
	The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. In the event of impairment, the Company would discount the future cash flows using its then estimated incremental borrowing rate to estimate the amount of the impairment.
	The Company assesses goodwill for potential impairment at the end of each fiscal year, or during the year if an event or other circumstance indicates that the Company may not be able to recover the carrying amount of the asset. In evaluating goodwill for impairment, first qualitative factors are assessed to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount. If it is concluded that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then no further testing of the goodwill assigned to the reporting unit is required. However, if it is concluded that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then a two-step goodwill impairment test is performed to identify potential goodwill impairment and measure the amount of goodwill impairment to be recognized, if any.
	In the first step of the review process, the estimated fair value of the reporting unit is compared with its carrying value. If the estimated fair value of the reporting unit exceeds its carrying amount, no further analysis is needed.
	If the estimated fair value of the reporting unit is less than its carrying amount, a second step of the review process is performed in order to calculate the implied fair value of the reporting unit goodwill in order to determine whether any impairment is required. The implied fair value of the reporting unit goodwill is then calculated by allocating the estimated fair value of the reporting unit to all of the assets and liabilities of the reporting unit as if the reporting unit had been acquired in a business combination. If the carrying value of the reporting unit’s goodwill exceeds the implied fair value of the goodwill, the Company then recognizes an impairment loss for that excess amount. During the year ended December 31, 2012, the Company determined that the goodwill it had recognized in connection with its previous acquisition of Cornerstone Conservation Group LLC had been impaired and accordingly recognized an impairment charge of $2,637,760 to reduce its carrying amount to zero.
	Stock-based compensation
	The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.
	Common Stock Purchase Warrants
	The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
	Accounting for Uncertainty in Income Taxes
	The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
	Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our consolidated financial statements. Our evaluation was performed for the tax years ended December 31, 2010, 2011, 2012 and 2013, the tax years which remain subject to examination by major tax jurisdictions as of December 31, 2013.
	We may from time to time be assessed interest or penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to our financial results. In the event we have received an assessment for interest and/or penalties, it has been classified in the consolidated financial statements as general and administrative expense.
	Research and Development Costs
	The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $459,651 and $1,321,214 for the years ended December 31, 2013 and 2012, respectively.
	Earnings (Loss) Per Share
	Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Basic earnings (loss) per share is computed by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be antidilutive. Excluded from weighted average common shares outstanding on a diluted basis were warrants exercisable for 7,586,000 shares and options for 2,750,000 shares for December 31, 2013 and warrants exercisable for 6,050,999 shares and options for 2,750,000 shares for December 31, 2012.
	Financial instruments
	The Company carries cash and cash equivalents, accounts receivable, accounts payable and accrued expenses at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature. The Company also carries notes payable to related parties at historical cost less discounts from warrants issued as loan financing costs.
	Fair value of financial assets and liabilities
	The Company measures the fair value of financial assets and liabilities in accordance with GAAP which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
	GAAP defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. GAAP describes three levels of inputs that may be used to measure fair value:
	Level 1 – quoted prices in active markets for identical assets or liabilities
	Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
	The Company generally does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has entered into certain other financial instruments and contracts, such as debt financing arrangements and freestanding warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. These instruments are required to be carried as derivative liabilities, at fair value.
	The Company uses the Black-Scholes option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to measure the fair value of these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective inputs that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the Company’s trading market price and the trading market price of various peer companies, which have historically had high volatility. Since derivative financial instruments are initially and subsequently carried at fair value, the Company’s income will reflect the volatility in these estimate and assumption changes.
	The Company reports its derivative liabilities at fair value on the accompanying consolidated balance sheets.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Recent_Accounting_Prouncements

Recent Accounting Prouncements	12 Months Ended
	Dec. 31, 2013
Recent Accounting Prouncements	'
Recent Accounting Pronouncements	'
	Note 4 – Recent Accounting Pronouncements
	In July 2013, the FASB issued guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carry forward exists. This guidance requires the unrecognized tax benefit to be presented in the financial statements as a reduction to a deferred tax asset. When a deferred tax asset is not available, or the asset is not intended to be used for this purpose, an entity should present the unrecognized tax benefit in the financial statements as a liability. The guidance will become effective for us at the beginning of our second quarter of fiscal 2014. We do not expect the adoption of this guidance will have a material impact on our consolidated financial statements.
	In January 2013, the FASB issued guidance clarifying the scope of disclosure requirements for offsetting assets and liabilities. The amended guidance limits the scope of balance sheet offsetting disclosures to derivatives, repurchase agreements, and securities lending transactions to the extent that they are offset in the financial statements of subject to an enforceable master netting arrangement or similar agreement. The guidance will become effective for us at the beginning of our first quarter of fiscal 2014. We do not expect the adoption of this guidance will have a material impact on our consolidated financial statements.

Acquisition

Acquisition	12 Months Ended
	Dec. 31, 2013
Acquisition	'
Acquisition	'
	Note 5 – Acquisition
	On March 30, 2012, the Company purchased 100% of the membership interests of Cornerstone Conservation Group LLC (“Cornerstone”) pursuant to a Membership Interest Purchase Agreement (the “Agreement”). Cornerstone’s main asset is its proprietary Combined Cooling, Heating and Power (“CCHP”) technology, which utilizes waste heat from commercial and residential heating, ventilation air conditioning and refrigeration (“HVACR”) systems.
	Cornerstone also has substantial experience and technology relating to geothermal or ground source heat pumps. The Company also moved its operations to a 5,000 square foot facility owned by one of the sellers in Scottsdale, Arizona. The Company has been using the facility rent free on a short term basis but expects to negotiate a lease on fair market terms.
	In consideration for the 100% membership interests in Cornerstone, the Company issued 2,260,000 shares of the Company’s common stock (valued at $1.37 per share, the closing price on March 30, 2012) to the selling members of Cornerstone and issued to the sellers fully vested three–year warrants to purchase an aggregate of 300,000 shares of the Company’s common stock as follows:
		(i)	100,000 shares at an exercise price of $2.00 per share, exercisable beginning January 1, 2012, through December 31, 2016;
		(ii)	100,000 shares at an exercise price of $3.00 per share, exercisable beginning July 1, 2012, through June 30, 2017; and
		(iii)	100,000 shares at an exercise price of $4.00 per share, exercisable beginning January 1, 2013, through December 31, 2017.
	The estimated fair value of the total warrants issued in connection with the acquisition of Cornerstone was $201,000 which was calculated using the Black-Scholes option valuation method with the following assumptions: a risk free interest rate of 1.04 percent, an estimated volatility of 79.1 percent and no dividend yield.  The total present value of all consideration expected to be paid as part of this agreement was $3,297,200.
	The following summarizes the fair values of the assets acquired:
	Intangible asset – Intellectual Property		$	659,440
	Goodwill			2,637,760
	Total assets acquired			3,297,200
	Aggregate purchase price		$	3,297,200
	The assets acquired were recorded based on estimates of their fair values determined by management, based on information then available and on assumptions as to future operations.
	Due to the departure of a key employee and as part of the Company’s annual impairment analysis, the goodwill associated with this acquisition was determined to be impaired at December 31, 2012 and accordingly, it was written off in that period.
	For the period ending December 31, 2013, amortization expense was $219,813 and accumulated amortization of the intangible asset-intellectual property was $384,673.
	Future amortization of the intangible asset – intellectual property was as follows as of December 31, 2013:
	Year ending December 31:
	2014		$	219,814
	2015			54,953
	Total		$	274,767

Property_Plant_and_Equipment

Property, Plant, and Equipment	12 Months Ended
	Dec. 31, 2013
Property, Plant, and Equipment:	'
Property, Plant and Equipment Disclosure	'
	Note 6 – Property and Equipment
	A summary of property and equipment at December 31, 2013 and December 31, 2012 is as follows:
		2013			2012			Estimated Useful Lives(in years)
	Equipment	$	83,146		$	25,426			5
	Computer equipment (hardware)		6,975			6,975			5-Mar
	Software		3,929			3,929			3
			94,050			36,330
	Less: Accumulated depreciation		(38,616	)		(26,771	)
		$	55,434		$	9,559
	The amounts charged to operations for depreciation expense for the year ended December 31, 2013 and 2012 were $11,845 and $6,250 respectively. Depreciation expense from inception through December 31, 2013 was $38,616.

Intangible_Assets_Goodwill_and

Intangible Assets, Goodwill and Other	12 Months Ended
	Dec. 31, 2013
Intangible Assets, Goodwill and Other:	'
Intangible Assets Disclosure	'
	Note 7 – Goodwill – Impairment Testing
	In accordance with ASU 2011-08, management of the Company undertook a qualitative assessment to determine whether it was more likely than not that the fair value of the assets acquired in the acquisition of Cornerstone Conservation Group were less than the carrying amount assigned to the assets in the acquisition accounting. This assessment resulted in the conclusion that it was more likely than not that the fair value of assets was less than the current carrying amount upon which management proceeded to perform the two-step goodwill impairment test described in ASC 350.
	In the acquisition of Cornerstone, significant value was placed upon the substantial experience, proprietary industry knowledge and business acumen of the managing member, and the value that he would bring to the management team of PowerVerde, Inc. This value was recorded as goodwill in the acquisition accounting. The managing member resigned as an officer and director of PowerVerde in the first quarter of 2013. Based on this event, the departure of a key asset of the Cornerstone Acquisition, the Company determined that the implied fair value of the goodwill recorded in the acquisition accounting no longer existed and an impairment charge of $2,637,760 was recognized in December 2012. This charge is reported on the consolidated 2012 statement of operations as an operating expense, Goodwill impairment. As of December 31, 2012, the carrying value of the goodwill was zero.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2013
Equity:	'
Stockholders' Equity	'
	Note 8 – Stockholders’ Equity
	Warrants
	During January through December 2011, the Company issued warrants to purchase 2,000,000 unregistered shares of the Company’s common stock at an exercise price of $0.75 per share in association with stock subscription agreements. These warrants expire on various dates through 2014. As of December 31, 2013, all of these warrants were outstanding.
	The Company issued warrants on June 3, 2011 to various persons, including affiliates of the Company, for services provided to the Company. These warrants covered the purchase of 1,855,000 unregistered shares of the Company’s stock at an exercise price of $1.05 per share with a five-year term. These share-based payments have been accounted for in accordance with ASC 815-40 using the Black Scholes warrant pricing model to determine the fair value of each warrant. As of December 31, 2013, all of these warrants were outstanding.
	On February 3, 2012, The Company issued warrants to purchase 500,000 unregistered shares of the Company’s common stock at an exercise price of $3.00 per share with a five-year term for settlement of certain disputed amounts (See Note 8). These share-based payments have been accounted for in accordance with ASC 815-40 using the Black-Scholes warrant pricing model to determine the fair value of each warrant. As of December 31, 2013, all of these warrants were outstanding.
	In connection with the acquisition of Cornerstone (See Note 5), on March 30, 2012, the Company issued warrants to purchase 300,000 unregistered shares of common stock at exercise prices ranging from $2.00 to $4.00 per share. These warrants expire at various dates through December 2017. As of December 31, 2013, all of these warrants were outstanding.
	During the second quarter of 2012, the Company issued warrants to purchase 335,000 unregistered shares of the Company’s common stock at an exercise price of $3.00 per share in association with stock subscription agreements. These warrants expire on various dates through 2015. As of December 31, 2013, all of these warrants were outstanding.
	During the third quarter of 2012, the Company issued warrants to purchase 71,000 unregistered shares of the Company’s common stock at an exercise price of $3.00 per share in association with stock subscription agreements. These warrants expire July 30, 2015. As of December 31, 2013, all of these warrants were outstanding.
	During the fourth quarter of 2012, the Company issued warrants to purchase 225,000 unregistered shares of the Company’s common stock at an exercise price of $1.00 per share in association with stock subscription agreements. These warrants expire October 31, 2015. As of December 31, 2013, all of these warrants were outstanding.
	In December 2012, the Company issued warrants to purchase 325,000 unregistered shares of the Company’s common stock at an exercise price of $.41 per share in association with the Secured Promissory Note (See Note 10). These warrants expire December 31, 2015. As of December 31, 2013, all of these warrants were outstanding.
	During January 2013, the Company issued three-year warrants to purchase 75,000 unregistered shares of the Company’s common stock at an exercise price of $0.41 per share in association with the Secured Promissory Note (See Note 8). These warrants expire December 31, 2015. As of December 31, 2013, all of these warrants were outstanding.
	During March 2013, the Company issued its Chief Executive Officer and Chief Financial Officer five –year warrants to purchase common stock at an exercise price of $0.30 per share (market price on date of grant) in the amounts of 1,000,000 and 500,000 shares, respectively. The Company recognized $210,000 in compensation expense. As of December 31, 2013, all of these warrants were outstanding.
	On December 1, 2013, the Company issued additional three-year warrants to purchase 400,000 unregistered shares of the Company’s common stock at an exercise price equal to $0.21 per share (the average closing price of the common stock during the 10 trading days prior to December 1, 2013). This was in association with the Secured Promissory Note (See Note 8). These warrants expire December 31, 2016. As of December 31, 2013, all of these warrants were outstanding.
	Expenses related to warrants issued in conjunction with settlement of certain disputes for the years ended December 31, 2013 and 2012 were $0 and $262,700, respectively.
	A summary of warrants issued, exercised and expired during the year ending December 31, 2013 is as follows:
		Shares			WeightedAverageExercisePrice			AggregateIntrinsicValue
	Balance at December 31, 2012		6,050,999		$	1.12		$	—
	Issued		1,975,000			0.29			—
	Expired		(439,999	)		(.75	)		—
	Balance at December 31, 2013		7,586,000		$	0.92		$	45,000
	The weighted average grant date fair value of warrants issued during the year ended December 31, 2013 amounted to $0.28 per warrant. The fair value of each warrant granted for equity and debt raises was determined using the Black-Scholes warrant pricing model and the following assumptions:
			December 31, 2013
	Risk free interest rate		.59%  to .84	%
	Expected term		3-5 years
	Annualized volatility		85%  to 90	%
	Expected dividends		—
	The expected term of warrants granted is based on historical experience with past warrant holders, and represents the period of time that warrants granted are expected to be outstanding.
	The warrant shares referred to above are unregistered shares of the Company’s stock and are restricted from trading as defined under Rule 144 of the United States Securities Act of 1933.
	Common Stock Issued for Services
	In the first quarter of 2013, the Company issued 125,000 common shares to a third party for six months consulting services and 200,000 common shares were issued to an employee as part of his compensation package. The expense for the period of $124,750 is included in the general and administrative expenses on the consolidated statement of operations.
	Private Placement of Common Stock
	In February 2012, the Company raised $500,000 exclusively from accredited European investors (including $275,000 from a Newton affiliate) pursuant to a private placement of 500,000 shares of common stock at a price of $1.00 per share. There were no warrants issued pursuant to this round; however, simultaneously Newton affiliates received three-year warrants to purchase 500,000 shares at $1.00 per share in connections with the settlement of certain claims by and between the Company and Newton.
	In the second quarter of 2012, the Company raised gross proceeds of $335,000 through the private placement of 335,000 unregistered shares of common stock to accredited investors at $1.00 per share. Each investor received a three-year warrant to purchase shares of common stock at $3.00 per share for a number of shares equal to the number of shares purchased by the investor in this offering. The Company paid a 10% commission on the gross proceeds of this offering to its placement agent.
	In the third quarter of 2012, the Company raised gross proceeds of $71,000 through the private placement of 71,000 unregistered shares of common stock to accredited investors at $1.00 per share. Each investor received a three-year warrant to purchase shares of common stock at $3.00 per share for a number of shares equal to the number of shares purchased by the investor in this offering. The Company paid a 10% commission on the gross proceeds of this offering to its placement agent.
	In the fourth quarter of 2012, the Company raised gross proceeds of $492,030 through the private placement of 396,000 unregistered shares of common stock to accredited investors at $.43 per share and 450,000 shares at $.715 per share. Each investor who purchased the common stock at $.715 per share received a three-year warrant to purchase additional shares of common stock at $1.00 per share for a number of shares equal to one-half of the number of shares purchased by the investor in this offering. The Company paid a 10% commission on the gross proceeds of this offering to its placement agent.
	In the second quarter of 2013, the Company raised gross proceeds of $125,000 through private placement of 500,000 unregistered shares of common stock to accredited investors at $.25 per share.
	In the third quarter of 2013, the Company raised gross proceeds of $150,000 through private placement of 600,000 unregistered shares of common stock to accredited investors at $.25 per share.
	In the fourth quarter of 2013, the Company raised gross proceeds of $25,000 through private placement of 100,000 unregistered shares of common stock to accredited investors at $.25 per share.
	Treasury Shares
	On April 7, 2011, 4,500,000 shares of the Company’s stock were surrendered to Treasury in exchange for a $200,000 interest-free note payable due in April 2013. The note payable is reported as note payable to related party on the accompanying consolidated balance sheets. In accordance with GAAP, the Company has discounted this obligation at an imputed rate of 8%. The balance was settled on October 16, 2012 with the surrender of 3,000,000 shares of the Company’s stock to Treasury in exchange for $530,000 as discussed below.
	In April 2012, the Company purchased 100,000 shares of common stock from an affiliate at a price of $.25 per share. Of the $25,000 purchase price, $14,000 was paid in 2011 and the balance in April 2012. The shares have been held as treasury stock from the date of closing.
	In May 2012, the Company purchased 450,000 shares of its common stock from an affiliate at a price of $0.20 per share. Of the $90,000 purchase price, $10,000 was paid at closing and the balance is payable $10,000 per month through January 2013. The payable has a balance of $5,000 and $33,000 at December 31, 2013 and 2012, respectively, and is included in “Payable to related parties” in the accompanying condensed consolidated balance sheets. The shares have been held as treasury stock from the date of closing.
	On October 16, 2012, 3,000,000 shares of the Company’s stock were surrendered to Treasury in exchange for $530,000, $100,000 of which is due in six equal monthly installments, beginning on November 16, 2012. The Company only made one of the required payments during 2013 and the payment schedule was renegotiated in the first quarter of 2014. The payable has a balance of $100,000, including accrued interest, as of December 31, 2013 and is included in the “Payable to related parties” in the accompanying consolidated balance sheets. In the event that any amount due remains unpaid, some or all amounts can be converted into shares of the Company’s stock at a price of $.0667 per share. The shares have been held as treasury stock from the date of closing. In accordance with ASC 470-20, “Debt with Conversion and Other Options,” the Company determined that the non-mandatory conversion feature represents a beneficial conversion feature that should be recorded as equity based on intrinsic value. The offset will be recorded as a discount and netted against the payable during the fourth quarter of 2013 (See Note 13).
	In October 2013, the Company and its Co-Founder George Konrad entered into an extension agreement whereby the due date of the $95,000 convertible debt owed to him was extended so that $50,000 was to be payable in November 2013 and $50,000 is payable in December 2013, in exchange for an increase in the amount due to $100,000.

Stock_Options

Stock Options	12 Months Ended
	Dec. 31, 2013
Stock Options	'
Stock Options	'
	Note 9 – Stock Options
	Stock option activity for the year ended December 31, 2013, is summarized as follows:
		Shares		WeightedAverageExercise Price		WeightedAverageRemainingContractualLife (Years)		AggregateIntrinsicValue
	Options outstanding at December 31, 2012		2,750,000	$	0.78		10	$	—
	Granted		—		—		—		—
	Expired/forfeited		—		—		—		—
	Options outstanding at December 31, 2013		2,750,000	$	0.78		10	$	—
	Total stock-based compensation for the years ended December 31, 2013 and 2012 was $121,237 and $658,381 respectively.
	There is no unrecognized stock compensation expense at December 31, 2013.

Notes_Payable_to_Related_Parti

Notes Payable to Related Parties	12 Months Ended
	Dec. 31, 2013
Notes Payable to Related Parties	'
Notes Payable to Related Parties	'
	10. Notes Payable to Related Parties
	In the fourth quarter of 2012, in an effort to raise capital, the Company entered into various Secured Promissory Note agreements with accredited investors, who are also existing stockholders of the Company. As of December 31, 2013, $400,000 was raised, of which $325,000 was raised in 2012 and $75,000 in the first quarter 2013. Upon closing, the Company issued to the investors three-year warrants for the purchase of 400,000 shares (in the aggregate) of the Company’s common stock at a price of $.41 per share and a commitment to issue additional warrants on December 1, 2013. On December 1, 2013, the Company issued additional three year warrants for 400,000 shares to the investors at an exercise price equal to $.21 per share (the average price of the common stock during the 10 trading days prior to December 1, 2013).
	The promissory notes bear interest at the rate of 10% per annum based on a 365-day year. Accrued interest will be paid semi-annually on June 30, 2013, December 31, 2013, June 30, 2014, and December 31, 2014. The entire principal balance of the Note, together with all unpaid interest accrued thereon, shall be due and payable on December 31, 2014. In the event the Company defaults on interest and/or principal payments, the Company will use all accounts receivable obtained now or hereafter existing, pursuant to the License Agreement from VDF FutureCeuticals Inc. (the “Licensee”), as collateral.
	The Company analyzed the terms of the warrants based on the provisions of ASC 480, “Distinguishing Liabilities from Equity,”  and determined that the warrants issued in conjunction with the closing of the notes payable qualified for equity accounting. The warrants that were issued on December 1, 2013 were classified as derivative liabilities until issuance on December 1, 2013. On December 1, 2013 the Company determined that the warrants qualified as equity accounting and as such the Company reclassified the fair value of the derivative liability to equity at December 1, 2013 (see Note 11).
	Under guidance in ASC 470, the Company allocated the $400,000 in proceeds proportionately between the Secured Promissory Note and the common stock warrants issued to the note holders based on their relative fair values. The relative fair value of the common stock warrants was $176,000, of which $88,000 ($16,500 in Q1 2013) was recorded as additional paid in capital and $88,000 ($16,500 in Q1 2013) was recorded as a derivative liability. The Secured Promissory Note was recorded at the principal amount of $400,000 less a discount of $176,000. This discount is being amortized to interest expense over the term of the Secured Promissory Note to related parties using the effective interest method. The fair value of the common stock warrants issued in conjunction with the Secured Promissory Notes was determined using the Black-Scholes pricing model. The Company determined the fair value of its common stock warrants to be $0.22 per warrant issued with an exercise price of $0.41 per warrant.
	Upon payment in full of the notes, a $25,000 fee will be paid by the Company to its placement agent, Martinez-Ayme Securities, Inc. Subsequently, the agreed upon amount was reduced to $20,000. In the fourth quarter of 2013, Martinez-Ayme Securities transferred the receivable to Richard Davis. As of December 31, 2013, $4,000 has been paid on this liability. The balance of $16,000 is reflected as a note payable to related parties in the accompanying consolidated balance sheets.
	On May 19, 2013, the Company entered into a Promissory Note with Edward Gomez, a Company shareholder, for $30,000. The promissory note bears interest at the rate of 10% per annum based on a 365-day year. The entire principal balance, along with the accrued interest is due on May 19, 2014.

Derivative_Liabilities

Derivative Liabilities

12 Months Ended

Dec. 31, 2013

Derivative Liabilities

'

Derivative liabilities

'

11. Derivative liabilities

The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has entered into certain other financial instruments and contracts, such as debt financing arrangements with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. These instruments are required to be carried as derivative liabilities, at fair value.

The following table discloses the fair value of the Company’s derivative liabilities as of December 31, 2013 and 2012. The Company held no asset derivatives at either reporting date.

Liability Derivatives

December 31, 2013

December 31, 2012

Balance SheetLocation

FairValue

Balance SheetLocation

FairValue

Derivatives not designated as hedging instruments

Secured Promissory Notes Warrants

Derivative Liabilities

$

0

Derivative Liabilities

$

68,250

The following table summarizes liabilities measured at fair value on a recurring basis for the periods presented:

December 31, 2013

December 31, 2012

Fair Value Measurements Using:

Level 1

Level 2

Level 3

Total

Level 1

Level 2

Level 3

Total

Liabilities

Derivative Liabilities

$

—

$

—

$

—

$

—

$

—

$

68,250

$

—

$

68,250

Commitment_and_Contingencies

Commitment and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitment and Contingencies:	'
Commitments and Contingencies	'
	12. Commitments and Contingencies
	On September 29, 2011, the Company entered into a license agreement (the “License Agreement”) with Newton Investments BV. Pursuant to the License Agreement, Newton will, for a period of 10 years, hold the exclusive manufacturing and distribution rights for the Systems in the 27 countries which are currently members of the European Union, subject to Newton’s achieving minimum sales of at least 100 Systems per year beginning in the second year of the License Agreement, payment of a royalty equal to 20% of the gross sales price of each System sold, and other terms and conditions set forth in the License Agreement. Due to ongoing technical problems with the Company’s Systems, the Company has deferred commencement of the minimum sales requirement until the problems are resolved.
	On October 25, 2012, the Company entered into a consulting agreement with Hank Leibowitz, the principal of Waste Heat Solutions, LLC, an expert with 39 years’ experience in the field of advanced energy systems. Pursuant to this consulting agreement, which is terminable by either party on 30 days’ notice, the Company pays Waste Heat Solutions, $5,000 per month through February 2013 and $7,500 per month thereafter. In connection with this consulting agreement, the Company issued to Waste Heat Solutions (i) a fully vested 10-year option to purchase 500,000 shares of common stock at $.56 per share and (ii) a 10-year option, vesting six months from the contract date, i.e., on April 25, 2013, to purchase an additional 500,000 shares at $.56 per share. The fair value of the fully vested option was approximately $182,000 and was recorded as general and administrative expenses in the consolidated statement of operations during 2012. The fair value of the option vesting six months from the contract date was approximately $182,000 of which approximately $61,000 was recorded as research and development expense in the consolidated statement of operations during 2012. Approximately $91,000 was recorded during the first quarter of 2013 and the remaining $30,000 was recognized in the second quarter of 2013. All amounts were recorded in research and development expense in the accompanying consolidated statements of operations.
	This consulting agreement contains standard confidentiality provisions, as well as standard non-competition and non-soliciting provisions which survive for two years following termination of the consultancy.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Taxes:	'
Income Tax Disclosure	'
	Note 13 – Income Taxes
	Deferred income taxes are provided based on the provisions of ASC Topic 740, “Accounting for Income Taxes”, to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	The Company did not have any tax positions for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within the next 12 months. The tax years that remain subject to examination by major taxing jurisdictions are those for the years ended December 31, 2013, 2012, 2011 and 2010.
	The Company classifies interest and penalties arising from underpayment of income taxes in the consolidated statements of operations as general and administrative expenses. As of December 31, 2013, the Company had no accrued interest or penalties related to uncertain tax provisions.
	Significant components of the Company’s net deferred income taxes are as follows:
		For the Years ended
		December 31,
		2013			2012
	Deferred tax assets:
	Net operating loss carryforwards	$	2,092,216		$	1,690,212
	Start-up cost		381,070			448,156
	Goodwill		871,272			989,819
	Amortization of IP		(6,893	)		—
	Stock based compensation		542,836			686,288
	Other		1,653			3,420
	Deferred tax assets		3,882,154			3,817,895
	Less valuation allowance		(3,882,154	)		(3,817,895	)
	Net deferred tax assets after valuation allowance	$	—		$	—
	A reconciliation of the U.S. statutory federal income tax rate to the effective income tax rate (benefit) follows:
	Rate Reconciliation	For the Years ended
		December 31,
		2013			2012
	Federal income tax at statutory rate	$	(358,686	)	$	(1,616,870	)
	State Tax		(58,023	)		(261,553	)
	Permanent Differences		(13,829	)		1,248
	Forfeiture of fully vested stock compensation		255,438			—
	Rate Change from 39.5% to 37.63%		88,950			—
	Other		21,891			(5,587	)
	Change in Valuation Allowance		64,259			1,882,762
		$	—		$	—
	In assessing the ability to realize a portion of the deferred tax assets, management considers whether it is more than likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities and projected future taxable income in making the assessment. After consideration of the evidence, both positive and negative, management has determined that a $3,882,154 valuation allowance at December 31, 2013 is necessary to reduce the deferred tax assets to the amount that will more likely than not be realized. The change in the valuation allowance for the current year is $64,259, as opposed to $1,882,762 on December 31, 2012. At December 31, 2013, the Company has available net operating loss carry forwards for federal income tax purposes of $5,262,149 expiring at various times from 2027 through 2032.
	Valuation and Qualifying Accounts
	Description	Balance at			Charged to			Write-offs	Other	Balance at
		Beginning			Cost and				Charges	End of
		of Period			Expenses					Period
	Deferred tax asset valuation allowance
	Year ended December 31, 2013	$	3,817,895		$	64,259				$	3,882,154
	Year ended December 31, 2012	$	1,935,133		$	1,882,762				$	3,817,895

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions	'
Related Party Transactions	'
	Note 13 – Related Party Transactions
	See Notes 8 and 10 for discussion of transactions with the Company’s Co-Founders, George Konrad and Fred Barker.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events:	'
Subsequent Events	'
	Note 14 – Subsequent Events
	In the first quarter of 2014, the Company raised gross proceeds of $240,000 through private placement of 2,400,000 unregistered shares of common stock to accredited investors at $.10 per share.
	On February 3, 2014, the Company paid $25,000 to George Konrad pursuant to its October 16, 2012 settlement agreement with Mr. Konrad, as amended. On February 7, 2014, the Company entered into a further amendment to the agreement pursuant to which Mr. Konrad agreed to waive all prior defaults under the agreement, as amended, in exchange for the Company’s agreement to either (i) pay $75,000 to him or (ii) issue 1,125,000 shares of common stock to him, by March 31, 2014, in full satisfaction of the Company’s obligations to him.

Accounting_Policies_Policies

Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies	'
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of PowerVerde, Inc. and its wholly-owned subsidiary, PowerVerde Systems, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.
Development Stage Company	'
	Development Stage Company
	The Company is a development stage company as defined in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 915, “Development Stage Entities”. The Company is devoting substantially all of its present efforts to establish a new business and none of its planned principal operations have commenced. All losses accumulated since inception has been considered as part of the Company’s development stage activities.
Cash Equivalents	'
	Cash Equivalents
	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Accounts Receivables	'
	Accounts Receivable
	Accounts receivable consist of balances due from sales and royalties. The Company monitors accounts receivable and provides allowances when considered necessary. At December 31, 2013 and 2012, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.
Employee Advances	'
	Employee Advances
	The employee advances represent the payroll taxes due on the issuance of common stock as compensation.
Revenue Recognition	'
	Revenue Recognition
	Sales revenues and associated cost of sales are recognized when title of the goods sold pass to the buyer, when shipped and when accounts receivable are determined to be reasonable collectable. Certain sales agreements also require installation and training by PowerVerde once goods are received and accepted by the customer. The Company does not consider these agreements multiple elements arrangements as defined by ASC 605-25 “Revenue Recognition”, as the Company does not offer installation or training as services separate from the sale of its products at this time. Therefore, a “best estimate of selling price” or individual pricing in accordance with ASC 605-25 is undeterminable. The Company defers all revenues and costs of sales until the agreement is 100% complete.
	Licensing and royalty revenue from royalty agreements is recognized in accordance with the terms of the specific agreement.
Property and Equipment	'
	Property and Equipment
	Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.
Intellectual Property and Goodwill	'
	Intellectual Property and Goodwill
	The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. In the event of impairment, the Company would discount the future cash flows using its then estimated incremental borrowing rate to estimate the amount of the impairment.
	The Company assesses goodwill for potential impairment at the end of each fiscal year, or during the year if an event or other circumstance indicates that the Company may not be able to recover the carrying amount of the asset. In evaluating goodwill for impairment, first qualitative factors are assessed to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount. If it is concluded that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then no further testing of the goodwill assigned to the reporting unit is required. However, if it is concluded that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then a two-step goodwill impairment test is performed to identify potential goodwill impairment and measure the amount of goodwill impairment to be recognized, if any.
	In the first step of the review process, the estimated fair value of the reporting unit is compared with its carrying value. If the estimated fair value of the reporting unit exceeds its carrying amount, no further analysis is needed.
	If the estimated fair value of the reporting unit is less than its carrying amount, a second step of the review process is performed in order to calculate the implied fair value of the reporting unit goodwill in order to determine whether any impairment is required. The implied fair value of the reporting unit goodwill is then calculated by allocating the estimated fair value of the reporting unit to all of the assets and liabilities of the reporting unit as if the reporting unit had been acquired in a business combination. If the carrying value of the reporting unit’s goodwill exceeds the implied fair value of the goodwill, the Company then recognizes an impairment loss for that excess amount. During the year ended December 31, 2012, the Company determined that the goodwill it had recognized in connection with its previous acquisition of Cornerstone Conservation Group LLC had been impaired and accordingly recognized an impairment charge of $2,637,760 to reduce its carrying amount to zero.
Stock-based Compensation	'
	Stock-based compensation
	The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.
Common Stock Purchase Warrants	'
	Common Stock Purchase Warrants
	The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
Accounting for Uncertainty in Income Taxes	'
	Accounting for Uncertainty in Income Taxes
	The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
	Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our consolidated financial statements. Our evaluation was performed for the tax years ended December 31, 2010, 2011, 2012 and 2013, the tax years which remain subject to examination by major tax jurisdictions as of December 31, 2013.
	We may from time to time be assessed interest or penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to our financial results. In the event we have received an assessment for interest and/or penalties, it has been classified in the consolidated financial statements as general and administrative expense.
Research and Development Costs	'
	Research and Development Costs
	The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $459,651 and $1,321,214 for the years ended December 31, 2013 and 2012, respectively.
Earnings (Loss) Per Share	'
	Earnings (Loss) Per Share
	Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Basic earnings (loss) per share is computed by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be antidilutive. Excluded from weighted average common shares outstanding on a diluted basis were warrants exercisable for 7,586,000 shares and options for 2,750,000 shares for December 31, 2013 and warrants exercisable for 6,050,999 shares and options for 2,750,000 shares for December 31, 2012.
Financial instruments	'
	Financial instruments
	The Company carries cash and cash equivalents, accounts receivable, accounts payable and accrued expenses at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature. The Company also carries notes payable to related parties at historical cost less discounts from warrants issued as loan financing costs.
Fair value of financial assets and liabilities	'
	Fair value of financial assets and liabilities
	The Company measures the fair value of financial assets and liabilities in accordance with GAAP which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
	GAAP defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. GAAP describes three levels of inputs that may be used to measure fair value:
	Level 1 – quoted prices in active markets for identical assets or liabilities
	Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
	The Company generally does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has entered into certain other financial instruments and contracts, such as debt financing arrangements and freestanding warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. These instruments are required to be carried as derivative liabilities, at fair value.
	The Company uses the Black-Scholes option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to measure the fair value of these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective inputs that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the Company’s trading market price and the trading market price of various peer companies, which have historically had high volatility. Since derivative financial instruments are initially and subsequently carried at fair value, the Company’s income will reflect the volatility in these estimate and assumption changes.
	The Company reports its derivative liabilities at fair value on the accompanying consolidated balance sheets.
Use of Estimates	'
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Summarizes_the_fair_values_of_

Summarizes the fair values of the assets acquired (Tables)	12 Months Ended
	Dec. 31, 2013
Summarizes the fair values of the assets acquired	'
Summarizes the fair values of the assets acquired	'
	The following summarizes the fair values of the assets acquired:
	Intangible asset – Intellectual Property	$	659,440
	Goodwill		2,637,760
	Total assets acquired		3,297,200
	Aggregate purchase price	$	3,297,200

Future_amortization_of_the_int

Future amortization of the intangible asset intellectual property was as follows (Tables)	12 Months Ended
	Dec. 31, 2013
Future amortization of the intangible asset intellectual property was as follows	'
Future amortization of the intangible asset intellectual property was as follows	'
	Future amortization of the intangible asset – intellectual property was as follows as of December 31, 2013:
	Year ending December 31:
	2014	$	219,814
	2015		54,953
	Total	$	274,767

Schedule_of_Plant_Property_and

Schedule of Plant, Property and equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule of Plant, Property and equipment (Tables):	'
Property, Plant and Equipment	'
	A summary of property and equipment at December 31, 2013 and December 31, 2012 is as follows:
		2013			2012			Estimated Useful Lives(in years)
	Equipment	$	83,146		$	25,426			5
	Computer equipment (hardware)		6,975			6,975			5-Mar
	Software		3,929			3,929			3
			94,050			36,330
	Less: Accumulated depreciation		(38,616	)		(26,771	)
		$	55,434		$	9,559

Summary_of_warrants_Tables

Summary of warrants (Tables)	12 Months Ended
	Dec. 31, 2013
Summary of warrants:	'
Summary of warrants	'
	A summary of warrants issued, exercised and expired during the year ending December 31, 2013 is as follows:
		Shares			WeightedAverageExercisePrice			AggregateIntrinsicValue
	Balance at December 31, 2012		6,050,999		$	1.12		$	—
	Issued		1,975,000			0.29			—
	Expired		(439,999	)		(.75	)		—
	Balance at December 31, 2013		7,586,000		$	0.92		$	45,000

Weighted_average_assumptions_T

Weighted average assumptions (Tables)	12 Months Ended
	Dec. 31, 2013
Weighted average assumptions:	'
Weighted average assumptions	'
		December 31, 2013
	Risk free interest rate	.59%  to .84	%
	Expected term	3-5 years
	Annualized volatility	85%  to 90	%
	Expected dividends	—

Stock_option_activity_Tables

Stock option activity (Tables)	12 Months Ended
	Dec. 31, 2013
Stock option activity:	'
Stock option activity	'
	Stock option activity for the year ended December 31, 2013, is summarized as follows:
		Shares		WeightedAverageExercise Price		WeightedAverageRemainingContractualLife (Years)		AggregateIntrinsicValue
	Options outstanding at December 31, 2012		2,750,000	$	0.78		10	$	—
	Granted		—		—		—		—
	Expired/forfeited		—		—		—		—
	Options outstanding at December 31, 2013		2,750,000	$	0.78		10	$	—

Fair_value_of_the_Companys_der

Fair value of the Company's derivative liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Fair value of the Company's derivative liabilities:	'
Schedule of Derivative Liabilities at Fair Value	'
	The following table discloses the fair value of the Company’s derivative liabilities as of December 31, 2013 and 2012. The Company held no asset derivatives at either reporting date.
		Liability Derivatives
		December 31, 2013				December 31, 2012
		Balance SheetLocation		FairValue		Balance SheetLocation		FairValue
	Derivatives not designated as hedging instruments
	Secured Promissory Notes Warrants		Derivative Liabilities	$	0		Derivative Liabilities	$	68,250

Derivative_liabilities_measure

Derivative liabilities measured at fair value on a recurring basis (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative liabilities measured at fair value on a recurring basis:	'
Derivative liabilities measured at fair value on a recurring basis	'
	The following table summarizes liabilities measured at fair value on a recurring basis for the periods presented:
		December 31, 2013								December 31, 2012
	Fair Value Measurements Using:	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	Liabilities
	Derivative Liabilities	$	—	$	—	$	—	$	—	$	—	$	68,250	$	—	$	68,250

Schedule_of_Income_Taxes_and_d

Schedule of Income Taxes and deferred tax assets (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule of Income Taxes and deferred tax assets (Tables):	'
Schedule of Deferred Tax Assets and Liabilities	'
	Significant components of the Company’s net deferred income taxes are as follows:
		For the Years ended
		December 31,
		2013			2012
	Deferred tax assets:
	Net operating loss carryforwards	$	2,092,216		$	1,690,212
	Start-up cost		381,070			448,156
	Goodwill		871,272			989,819
	Amortization of IP		(6,893	)		—
	Stock based compensation		542,836			686,288
	Other		1,653			3,420
	Deferred tax assets		3,882,154			3,817,895
	Less valuation allowance		(3,882,154	)		(3,817,895	)
	Net deferred tax assets after valuation allowance	$	—		$	—
Schedule of Effective Income Tax Rate Reconciliation	'
	A reconciliation of the U.S. statutory federal income tax rate to the effective income tax rate (benefit) follows:
	Rate Reconciliation	For the Years ended
		December 31,
		2013			2012
	Federal income tax at statutory rate	$	(358,686	)	$	(1,616,870	)
	State Tax		(58,023	)		(261,553	)
	Permanent Differences		(13,829	)		1,248
	Forfeiture of fully vested stock compensation		255,438			—
	Rate Change from 39.5% to 37.63%		88,950			—
	Other		21,891			(5,587	)
	Change in Valuation Allowance		64,259			1,882,762
Summary of Valuation Allowance	'
	Valuation and Qualifying Accounts
	Description	Balance at			Charged to			Write-offs	Other	Balance at
		Beginning			Cost and				Charges	End of
		of Period			Expenses					Period
	Deferred tax asset valuation allowance
	Year ended December 31, 2013	$	3,817,895		$	64,259				$	3,882,154
	Year ended December 31, 2012	$	1,935,133		$	1,882,762				$	3,817,895

Nature_of_Business_and_organiz

Nature of Business and organization (Details) (USD $)	Feb. 11, 2008
Nature of Business and organization	'
Each issued and outstanding share of common stock of PowerVerde was converted into the right to receive shares of the common stock of Vyrex	1.2053301
Number of shares held by the former shareholders of PowerVerde as a result of the Merger	24,588,734
Percentage of shares held by the former shareholders of PowerVerde as a result of the Merger	95.00%
Pursuant to the Merger Agreement, PowerVerde paid in accounts payable and other liabilities owed by Vyrex	$233,000
The total purchase price of the transaction	401,894
Transaction costs related to the Merger included in the total purchase price	60,000
Vyrex paid a promissory note prior to execution of the Merger Agreement	$200,000
Shares of common stock issued for payment of promissory note	250,000
Additional shares of common stock issued as payment for certain consulting and administrative services	25,000

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Antidilutive Securities Excluded and Imapirment charges	'	'
Number of warrants excluded from weighted average common shares outstanding on a diluted basis.	7,586,000	6,050,999
Number of options excluded from weighted average common shares outstanding on a diluted basis.	2,750,000	2,750,000
Goodwill and intangible asset impairment charge recognized	$2,637,760	'

Acquisition_Cornerstone_Acquis

Acquisition - Cornerstone Acquisition - Purchase Price Allocation (Details) (USD $)	Dec. 31, 2013
Acquisition - Cornerstone Acquisition - Purchase Price Allocation	'
Intangible asset - Intellectual Property	$659,440
Goodwill	2,637,760
Total assets acquired	3,297,200
Aggregate purchase price	$3,297,200

Acquisition_Future_amortizatio

Acquisition - Future amortization of the intangible asset-intellectual property (Details) (USD $)	Dec. 31, 2013
Future Amortization Assets	'
Future Amortization 2014	$219,814
Future Amortization 2015	54,953
Total Future Amortization	$274,767

Acquisition_Narrative_Details

Acquisition Narrative (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Acquisition Narrative	'
Percentage of membership interests purchased	100.00%
Area of land owned by sellers in Scottsdale Arizona	5,000
Stock issued during period, shares, acquisitions	2,260,000
Share price (in Dollars per share)	$1.37
Exercise period of warrants (in years)	3
Warrants issued'	300,000
Amortization expenses	$219,813
Amortization of acquired intangible assets (in Dollars)	$384,673

Acquisition_Parentheticals_Det

Acquisition Parentheticals (Details) (USD $)	Apr. 30, 2012
Acquisition Parentheticals	'
Warrants For Cornerstone Acquisition Exercisable January 1, 2012 - December 31, 2016	100,000
Exercise price of these warrants	$2
Warrants for Cornerstone Acquisition Exercisable July 1, 2012 through June 30, 2017	100,000
Exercise price of these warrants,	$3
Warrants For Cornerstone Acquisition Exercisable January 1, 2013 through December 31, 2017	100,000
Exercise price of warrants issued in transaction (in Dollars per share)	$4
Warrants For Cornerstone Acquisition	300,000
Issuance of warrants in business acquisition, Value (in Dollars)	$201,000
Risk free interest rate	1.04%
Expected volatility rate	79.10%
Equity issued in business combination, fair value (in Dollars)	3,297,200

A_summary_of_property_and_equi

A summary of property and equipment at December 31, 2013 and December 31, 2012 is as follows: (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
A summary of property and equipment at :	'	'
Equipment.	$83,146	$25,426
Computer equipment (hardware).	6,975	6,975
Software.	3,929	3,929
Total Property and equipments	94,050	36,330
Less: Accumulated depreciation.	-38,616	-26,771
Net Property and equipments.	$55,434	$9,559

Summary_of_depreciation_expens

Summary of depreciation expenses (Details) (USD $)	12 Months Ended		82 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Summary of depreciation expenses	'	'	'
Depreciation expense for the year ended	$11,845	$6,250	$38,616

Goodwill_Impairment_Testing_De

Goodwill - Impairment Testing (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Goodwill - Impairment Testing	'	'
Goodwill impariment charge recognized in dec.2012	$0	$2,637,760

Issue_of_Warrants_to_purchase_

Issue of Warrants to purchase shares of the Company's common stock (Details) (USD $)	1 Months Ended		3 Months Ended			9 Months Ended	12 Months Ended
	Mar. 31, 2013	Jan. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Dec. 31, 2010	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Issue of Warrants to purchase shares of the Company's common stock	'	'	'	'	'	'	'	'	'
Company issued warrants to purchase unregistered shares of the Company's common stock	'	75,000	225,000	71,000	335,000	439,999	'	'	2,000,000
Exercise price per share in association with stock subscription agreements	'	$0.41	$1	$3	$3	$0.75	'	'	$0.75
Company issued its Chief Executive Officer five year warrants to purchase common stock	1,000,000	'	'	'	'	'	'	'	'
Company issued its Chief Financial Officer five year warrants to purchase common stock	500,000	'	'	'	'	'	'	'	'
Company recognized an amount in compensation expense	$210,000	'	'	'	'	'	'	'	'
Exercise price per share in association with stock issued to Chief Executive Officer and Chief Financial Officer	$0.30	'	'	'	'	'	'	'	'
Expenses related to warrants issued in conjunction with settlement of certain disputes	'	'	'	'	'	'	$0	$262,700	'

Warrants_transactions_Details

Warrants transactions (Details) (USD $)	Dec. 01, 2013	Dec. 31, 2012	Mar. 30, 2012	Feb. 03, 2012	Jun. 03, 2011
Warrants transactions	'	'	'	'	'
The Company issued warrants to various persons, including affiliates of the Company, for services provided to the Company	'	'	'	500,000	1,855,000
Company issued unregistered shares of the Company's stock at an exercise price per share	'	$0.41	'	$3	$1.05
Term period of exercising of warrants in years	'	'	'	5	5
Company issued unregistered shares of the Company's stock in connection with the acquisition of Cornerstone	'	'	300,000	'	'
Exercise price per share minimum range for warrants issued in connection with the acquisition of Cornerstone	'	'	$2	'	'
Exercise price per share maximum range for warrants issued in connection with the acquisition of Cornerstone	'	'	$4	'	'
Company issued unregistered shares of the Company's stock in connection with the issue of Secured Promissory Note	'	325,000	'	'	'
Company issued additional three-year warrants to purchase unregistered shares of the Company's common stock	400,000	'	'	'	'
Exercise price per share for additional three-year warrants to purchase unregistered shares of the Company's common stock	$0.21	'	'	'	'

Warrants_outstanding_as_on_dat

Warrants outstanding as on date (Details)	Dec. 31, 2013
Warrants outstanding as on date	'
Warrants expired or exercised out of issues made during January through December 2011	2,000,000
Warrants outstanding out of issue made on June 3, 2011	1,855,000
Warrants outstanding out of issue made on February 3, 2012	500,000
Warrants outstanding out of issue made in connection with the acquisition of Cornerstone	300,000
Warrants outstanding out of issue made during the second quarter of 2012	335,000
Warrants outstanding out of issue made during the third quarter of 2012	71,000
Warrants outstanding out of issue made during the fourth quarter of 2012	225,000
Warrants outstanding out of issue made In December, 2012	325,000
Warrants outstanding out of issue made during January 2013	75,000
Warrants outstanding out of issue made during March 2013 to Chief Executive Officer	1,000,000
Warrants outstanding out of issue made during March 2013 to Chief Financial Officer	500,000
Warrants outstanding out of additional three-year warrants issued to purchase unregistered shares of the Company's common stock on December 1, 2013	400,000

Common_Stock_Issued_for_Servic

Common Stock Issued for Services (Details) (USD $)	3 Months Ended
	Mar. 31, 2013	Dec. 31, 2013
Common Stock Issued for Services	'	'
Company issued common shares to a third party for six months consulting services	125,000	'
Common shares issued to an employee as part of his compensation package	200,000	'
The expense for the period included in the general and administrative expenses	'	$124,750

Treasury_Shares_transactions_D

Treasury Shares transactions (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Oct. 16, 2012	31-May-12	Apr. 30, 2012	Apr. 07, 2011
Treasury Shares transactions	'	'	'	'	'	'
Shares of the Company's stock were surrendered to Treasury in exchange for a interest-free note payable	'	'	'	'	'	4,500,000
Amount reported as note payable to related party	'	'	'	'	'	$200,000
Imputed rate of interest on note payable	'	'	'	'	'	8.00%
The balance of the note payable was settled with the surrender of an additional shares of the Company's stock	'	'	3,000,000	'	'	'
Value of note exchanged in Treasury	'	'	530,000	'	'	'
Company purchased shares of common stock from an affiliate	'	'	'	450,000	100,000	'
Purchase price of shares of common stock purchased from an affiliate	'	'	'	$90,000	$25,000	'
Purchase price per share of common stock purchased from an affiliate	'	'	'	$0.20	$0.25	'
Amount payable as equal monthly installments	'	'	100,000	10,000	'	'
Balance of payable included in the "Payable to related parties"	$5,000	$33,000	$100,000	$15,000	$9,000	'

Private_Placement_of_Common_St

Private Placement of Common Stock (Details) (USD $)	1 Months Ended	3 Months Ended
	Feb. 28, 2012	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012
Private Placement of Common Stock	'	'	'	'	'	'	'
Company raised exclusively from accredited European investors pursuant to a private placement	$500,000	'	'	'	'	'	'
Shares of common stock issued to European investors pursuant to a private placement	500,000	'	'	'	'	'	'
Price per share of common stock issued to European investors pursuant to a private placement	$1	'	'	'	'	'	'
Fund raised from a Newton affiliate	275,000	'	'	'	'	'	'
Newton affiliates received three-year warrants to purchase shares in connections with the settlement of certain claims by and between the Company and Newton	500,000	'	'	'	'	'	'
Company raised gross proceeds through the private placement of unregistered shares of common stock to accredited investors	'	$25,000	$150,000	$125,000	$492,030	$71,000	$335,000
Issue of unregistered shares of common stock to accredited investors	'	100,000	600,000	500,000	'	71,000	335,000
Price per share of common stock issuedto accredited investors	'	$0.25	$0.25	$0.25	'	$1	$1
Each investor received a three-year warrant to purchase shares of common stock at a price per share	'	'	'	'	$1	$3	$3
Issue of unregistered shares of common stock to accredited investors at $ 0.43 per share	'	'	'	'	396,000	'	'
Issue of unregistered shares of common stock to accredited investors .715 per share	'	'	'	'	450,000	'	'
Percentage of commission on the gross proceeds of offering paid to its placement agent.	'	'	'	'	10.00%	'	'

Summary_of_warrants_issued_exe

Summary of warrants issued, exercised and expired during the year (Details) Stockholders equity}	Shares	Weighted Average Exercise Price	Aggregate Intrinsic Value
Balance of warrants at Dec. 31, 2012	6,050,999	1.12	'
Issued	1,975,000	0.29	'
Expired	-439,999	-0.75	'
Balance of warrants. at Dec. 31, 2013	7,586,000	0.92	45,000

Weighted_average_grant_date_fa

Weighted average grant date fair value of warrants assumptions (Details)	12 Months Ended
	Dec. 31, 2013
Risk free interest rate minimum	0.59%
Risk free interest rate maximum	0.84%
Expected term minimum in years	3
Expected term maximum in years	5
Expected dividends	0.00%

Stock_option_activity_for_the_

Stock option activity for the year ended December 31, 2013, is summarized as follows (Details)	Options	Weighted Average Exercise Price Options	Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic value of options
Options outstanding. at Dec. 31, 2012	2,750,000	0.78	10	0
Options Granted	0	'	'	'
Options Expired/forfeited	0	'	'	'
Options outstanding, at Dec. 31, 2013	2,750,000	0.78	10	'

Notes_Payable_to_Related_Parti1

Notes Payable to Related Parties (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Fees payable to placement agent	$25,000
Accrued fees payable	20,000
Amount paid on this liability	4,000
Balance amount reflected in notes payable to related parties	$16,000

Notes_Payable_to_Related_Parti2

Notes Payable to Related Parties parentheticals (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Notes Payable to Related Parties parentheticals	'
Proceeds from notes payable to related parties.	$75,000
Proceeds from notes payable to related parties in 2012	325,000
Additional warrants issuable for purchase of common stock.	400,000
Number of trading days used for calculation of exercise price of additional warrant.	10
Interest rate of promissory note	10.00%
Fair value of the common stock warrants recorded as additional paid in capital	16,500
Fair value of the common stock warrants recorded as derivative liability	16,500
Principal amount of secured promissory note	400,000
Discount on issue of secured promissory note	176,000
Fair value of common stock per share (in dollars per share)	$0.41
Fair value of the common stock warrants recorded as additional paid in capital till date	88,000
Fair value of the common stock warrants recorded as derivative liability till date	88,000
Fair value of common stock warrants issued (in dollars per share)	$0.22
Promissory Note with Edward Gomez, a company shareholder	$30,000
Promissory note bears interest at	10.00%

The_following_table_summarizes

The following table summarizes liabilities measured at fair value on a recurring basis for the periods presented: (Details) (USD $)	Level 1	Level 2	Total (FVM)
Liabilities Balance. at Dec. 31, 2011	$0	'	'
Derivative Liabilities.	'	68,250	68,250
Liabilities Balance, at Dec. 31, 2012	0	'	'
Liabilities Balance. at Dec. 31, 2012	'	'	'
Derivative Liabilities,	'	0	0
Liabilities Balance,. at Dec. 31, 2013	$0	'	'

Derivative_liabilities_Derivat

Derivative liabilities (Derivative Liabilities, Derivatives not designated as hedging instruments) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Derivatives not designated as hedging instruments	'	'
Secured Promissory Notes Warrants	$0	$68,250

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	Oct. 25, 2012
Consulting agreement with Hank Leibowitz, the principal of Waste Heat Solutions, LLC,	'
Agreement terminable by either party notice period of days	30
Company pays waste heat solutions per month through Feb. 2013	$5,000
Company pays waste heat solutions per month thereafter Feb. 2013	7,500
Fully vested 10-year option issued to purchase shares of common stock at $.56 per share	500,000
Right to Purchase of additional shares for options vesting six months from the date of contract	500,000
Fair value of the options fully vested recorded as Research and development cost	182,000
Price per share of the 10 year options	$0.56
Fair value of option vesting was recorded during the fourth quarter of 2012	61,000
Amount recorded during the first quarter of 2013	91,000
Amount recorded in the second quarter of 2013	$30,000

Components_of_the_net_deferred

Components of the net deferred income tax asset (liability) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred income tax asset:	'	'
Net operating loss carry forwards	$2,092,216	$1,690,212
Start-up cost	381,070	448,156
Goodwill	871,272	989,819
Amortization of IP	-6,893	'
Stock based compensation'	542,836	686,288
Other assets.	1,653	3,420
Deferred tax assets	3,882,154	3,817,895
Less Valuation Allowance	-3,882,154	-3,817,895
Net deferred tax assets after valuation allowance	$0	$0

A_reconciliation_of_the_US_sta

A reconciliation of the U.S. statutory federal income tax rate to the effective income tax rate (benefit) follows: (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Rate Reconciliation	'	'
Federal income tax at statutory rate	($358,686)	($1,616,870)
State Tax	-58,023	-261,553
Permanent Differences	-13,829	1,248
Forfeiture of fully vested stock compensation	255,438	'
Rate Change from 39.5% to 37.63%	88,950	'
Other changes	21,891	-5,587
Change in Valuation Allowance	$64,259	$1,882,762

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred tax asset valuation allowance:	'	'
Deferred tax asset valuation allowance	$3,817,895	$1,935,133
Charged to cost and expenses	64,259	1,882,762
Deferred Tax Asset and Valuation Allowance at the end of the year	$3,882,154	$3,817,895

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
Subsequent Event	'
Proceeds from Issuance of Private Placement (in Dollars)	$240,000
Unregistered shares of common stock accredited to investors at $0.10 per share	2,400,000
Price per share of equity issued (in Dollars per share)	$0.10
Amount paid to George Konrad for settlement of agreement with Mr. Konrad	25,000
Increase in amount of convertible debt to be paid	100,000
Mr. Konrad agreed to waive all prior defaults under the agreement, in exchange for the Company's agreement to either pay an amount of	$75,000
Mr. Konrad agreed to waive all prior defaults under the agreement, in exchange for the Company's agreement to or issue common stock shares to him	1,125,000